{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:15:30Z","timestamp":1780413330562,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"DOI":"10.1007\/s00702-026-03189-x","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:46:59Z","timestamp":1780411619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in the diagnosis and management of functional movement disorders in a developing nation: insights from the Philippines"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1126-5597","authenticated-orcid":false,"given":"Kathleen Ann","family":"Pa\u00f1ares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1229-3667","authenticated-orcid":false,"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-4226","authenticated-orcid":false,"given":"Gerard","family":"Saranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"3189_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jamapsychiatry.2013.2842","volume":"71","author":"S Aybek","year":"2014","unstructured":"Aybek S, Nicholson TR, Zelaya F et al (2014) Neural correlates of recall of life events in conversion disorder. JAMA Psychiatry 71:52\u201360. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.2842","journal-title":"JAMA Psychiatry"},{"key":"3189_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1080\/09638288.2024.2373775","volume":"47","author":"H Bhatt","year":"2025","unstructured":"Bhatt H, MacGillivray L, Gilmour GS et al (2025) Integrated model of care for functional movement disorder: targeting brain, mind and body. Disabil Rehabil 47:1433\u20131441. https:\/\/doi.org\/10.1080\/09638288.2024.2373775","journal-title":"Disabil Rehabil"},{"key":"3189_CR4","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/mds.22618","volume":"24","author":"AJ Espay","year":"2009","unstructured":"Espay AJ, Goldenhar LM, Voon V et al (2009) Opinions and clinical practices related to diagnosing and managing patients with psychogenic movement disorders: An international survey of movement disorder society members. Mov Disord 24:1366\u20131374. https:\/\/doi.org\/10.1002\/mds.22618","journal-title":"Mov Disord"},{"key":"3189_CR3","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2018.1264","volume":"75","author":"AJ Espay","year":"2018","unstructured":"Espay AJ, Aybek S, Carson A et al (2018) Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol 75:1132\u20131141. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1264","journal-title":"JAMA Neurol"},{"key":"3189_CR5","doi-asserted-by":"publisher","unstructured":"Garcin B, Villain N, Mesrati F et al (2021) Demographic and clinical characteristics of patients with functional motor disorders: the prospective Salp\u00eatri\u00e8re cohort. https:\/\/doi.org\/10.1101\/2021.02.04.21251123","DOI":"10.1101\/2021.02.04.21251123"},{"key":"3189_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/B978-0-12-801772-2.00043-6","volume":"139","author":"J Gelauff","year":"2016","unstructured":"Gelauff J, Stone J (2016) Prognosis of functional neurologic disorders. Handb Clin Neurol 139:523\u2013541. https:\/\/doi.org\/10.1016\/B978-0-12-801772-2.00043-6","journal-title":"Handb Clin Neurol"},{"key":"3189_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/WCO.0b013e32832dc169","volume":"22","author":"A Gupta","year":"2009","unstructured":"Gupta A, Lang AE (2009) Psychogenic movement disorders. Curr Opin Neurol 22:430\u2013436. https:\/\/doi.org\/10.1097\/WCO.0b013e32832dc169","journal-title":"Curr Opin Neurol"},{"key":"3189_CR8","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1093\/brain\/awp060","volume":"132","author":"R Kanaan","year":"2009","unstructured":"Kanaan R, Armstrong D, Barnes P, Wessely S (2009) In the psychiatrists chair: How neurologists understand conversion disorder. Brain 132:2889\u20132896. https:\/\/doi.org\/10.1093\/brain\/awp060","journal-title":"Brain"},{"key":"3189_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11910-022-01192-9","volume":"22","author":"S Kola","year":"2022","unstructured":"Kola S, LaFaver K (2022) Updates in Functional Movement Disorders: from Pathophysiology to Treatment Advances. Curr Neurol Neurosci Rep 22:305\u2013311. https:\/\/doi.org\/10.1007\/s11910-022-01192-9","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3189_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1017\/S1092852920002138","volume":"26","author":"K Lafaver","year":"2021","unstructured":"Lafaver K, Lafrance WC, Price ME et al (2021) Treatment of functional neurological disorder: Current state, future directions, and a research agenda. CNS Spectr 26:607\u2013613. https:\/\/doi.org\/10.1017\/S1092852920002138","journal-title":"CNS Spectr"},{"key":"3189_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/JNNP-2021-328462","volume":"93","author":"SC Lidstone","year":"2022","unstructured":"Lidstone SC, Costa-Parke M, Robinson EJ et al (2022) Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases. J Neurol Neurosurg Psychiatry 93:609\u2013616. https:\/\/doi.org\/10.1136\/JNNP-2021-328462","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3189_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/mdc3.13757","volume":"10","author":"DDG Palmer","year":"2023","unstructured":"Palmer DDG, Gamble M, Higgins M et al (2023) Outcomes of an Integrated Multidisciplinary Clinic for People with Functional Neurological Disorder. Mov Disord Clin Pract 10:967\u2013973. https:\/\/doi.org\/10.1002\/mdc3.13757","journal-title":"Mov Disord Clin Pract"},{"key":"3189_CR13","doi-asserted-by":"publisher","unstructured":"Park JE (2018) Clinical characteristics of functional movement disorders: a clinic-based study. Tremor Other Hyperkinetic Movements 8. https:\/\/doi.org\/10.7916\/D81N9HK4","DOI":"10.7916\/D81N9HK4"},{"key":"3189_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cnp.2021.03.001","volume":"6","author":"G Saranza","year":"2021","unstructured":"Saranza G, Vargas-Mendez D, Lang AE, Chen R (2021) Suggestibility as a valuable criterion for laboratory-supported definite functional movement disorders. Clin Neurophysiol Pract 6:103\u2013108. https:\/\/doi.org\/10.1016\/j.cnp.2021.03.001","journal-title":"Clin Neurophysiol Pract"},{"key":"3189_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3988\/jcn.2023.0246","volume":"20","author":"T Schneider","year":"2024","unstructured":"Schneider T, Leemann B, Nicastro N, Schnider A (2024) Long-Term Outcome of Motor Functional Neurological Disorder After Rehabilitation. J Clin Neurol (Korea) 20:493\u2013500. https:\/\/doi.org\/10.3988\/jcn.2023.0246","journal-title":"J Clin Neurol (Korea)"},{"key":"3189_CR16","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/mds.23922","volume":"26","author":"P Schwingenschuh","year":"2011","unstructured":"Schwingenschuh P, Katschnig P, Seiler S et al (2011) Moving toward laboratory-supported criteria for psychogenic tremor. Mov Disord 26:2509\u20132515. https:\/\/doi.org\/10.1002\/mds.23922","journal-title":"Mov Disord"},{"key":"3189_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/practneurol-2015-001241","volume":"16","author":"J Stone","year":"2016","unstructured":"Stone J (2016) Functional neurological disorders: The neurological assessment as treatment. Pract Neurol 16:7\u201317. https:\/\/doi.org\/10.1136\/practneurol-2015-001241","journal-title":"Pract Neurol"},{"key":"3189_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1136\/bmj.38628.466898.55","volume":"331","author":"J Stone","year":"2005","unstructured":"Stone J, Smyth R, Carson A et al (2005) Systematic review of misdiagnosis of conversion symptoms and hysteria. Br Med J 331:989\u2013991. https:\/\/doi.org\/10.1136\/bmj.38628.466898.55","journal-title":"Br Med J"},{"key":"3189_CR19","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/brain\/awq068","volume":"133","author":"J Stone","year":"2010","unstructured":"Stone J, Warlow C, Sharpe M (2010) The symptom of functional weakness: A controlled study of 107 patients. Brain 133:1537\u20131551. https:\/\/doi.org\/10.1093\/brain\/awq068","journal-title":"Brain"},{"key":"3189_CR20","doi-asserted-by":"publisher","unstructured":"Tayeb HO (2023) Functional Neurological Disorder in Saudi Arabia: An Update. Cureus. https:\/\/doi.org\/10.7759\/cureus.47607","DOI":"10.7759\/cureus.47607"},{"key":"3189_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/jnnp-2020-323141","volume":"91","author":"BLC Thomsen","year":"2020","unstructured":"Thomsen BLC, Teodoro T, Edwards MJ (2020) Biomarkers in functional movement disorders: A systematic review. J Neurol Neurosurg Psychiatry 91:1261\u20131269. https:\/\/doi.org\/10.1136\/jnnp-2020-323141","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3189_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/mdc3.13077","volume":"7","author":"M Tinazzi","year":"2020","unstructured":"Tinazzi M, Morgante F, Marcuzzo E et al (2020) Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study. Mov Disord Clin Pract 7:920\u2013929. https:\/\/doi.org\/10.1002\/mdc3.13077","journal-title":"Mov Disord Clin Pract"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03189-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:47:00Z","timestamp":1780411620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03189-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":22,"alternative-id":["3189"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03189-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to this article\u2019s content.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The authors confirm that this study was approved by the Chong Hua Hospital Research Ethics Board (IRBi reference code: 2025-030).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Kathleen Ann Pa\u00f1ares has nothing to declare. Anthony E. Lang has served as an advisor for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, EG427, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB; received honoraria from Sun Pharma, AbbVie and Sunovion; received grants from Canadian Institutes of Health Research, Edmond J Safra Philanthropic Foundation, Krembil Brain Institute, Michael J. Fox Foundation, Parkinson Foundation, Parkinson Canada, and The Rossy Foundation; is serving as an expert witness in litigation related to paraquat and Parkinson\u2019s disease, received publishing royalties from Elsevier, Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press. Over the past 12 months, Gerard Saranza has received research and CME support from the Michael J. Fox Foundation through the Global Parkinson\u2019s Genetics Program (GP2) (MJFF-026331), CME support from the Internal Parkinson and Movement Disorder Society through the MDS Center to Center Program 2025\u20132027 (42400- CNT2CNT), and speaker\u2019s honoraria and CME support from various pharmaceutical companies in the Philippines (in alphabetical order): AbbVie Inc., Bharat Serums And Vaccines Limited (\n                      BSV\n                      ), Cathay Drug Company Inc., DKSH Philippines, E* Chimes Pharmaceutical Inc., Haleon Philippines (GlaxoSmithKline Consumer Healthcare Philippines), HI-Eisai Pharmaceutical, Inc., Hizon Laboratories, Inc., InnoGen Pharmaceuticals Inc, LRI-Therapharma, Lotus Pharmaceutical, Lundbeck Philippines, Inc., Medchoice Pharma Inc., Medichem Pharmaceutical Inc., Medtronic Philippines Inc., Menarini Philippines, Inc., Nestl\u00e9 Philippines, Inc., One Pharma Marketing Inc., Pfizer Philippines Inc., Sandoz Philippines Corp., Sun Pharma Philippines, Torrent Pharma Philippines, Inc., Unilab, Inc., Vexxa Lifesciences, and Zydus Healthcare Philippines Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosures for the previous 12 months"}}]}}